Pharmaceutical Investment Oversight and Accountability
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-07-23 — To amend the Public Health Service Act to require the Secretary of Health and Human Services to enforce certain requirements with respect to for-profit corporations that own health care systems, and for other purposes.: cross-connection with for-profit-healthcare-corporate-ownership: Both address oversight of for-profit/investor ownership structures in the health sector, with financial-services committee touchpoints. (novelty: 3)
- 2026-07-15 — Pharmaceutical Investment Oversight and Accountability Act: S4987 (Pharmaceutical Investment Oversight and Accountability Act) introduced in the 119th Congress and referred to Senate Banking, Housing, and Urban Affairs; only title and referral available, no bill text or specific oversight mechanisms yet disclosed. (novelty: 2)
Open questions
Related
Contributing findings
Pharmaceutical Investment Oversight and Accountability Act
15-jul-2026
novelty 2
per-area 2
introduces